Bank of America Corporation
BAC is still priced like a middling bank at 12.7x FY2025 EPS even as earnings power is stepping up on upper-end 6%-8% NII growth, stronger operating leverage, and disciplined capital return.
BAC is being valued like a stable but unexciting bank when the earnings path has turned better than that. The core disconnect is simple: the stock trades at 12.7x FY2025 EPS and only 2.05x sales, roughly in line to below peers, yet the operating profile has improved sharply. FY2025 already showed $191.6B of revenue, up 3.8%, and $3.88 of EPS, up 11.3%. Then Q2 2026 accelerated meaningfully, with $31.6B of revenue, up 15% YoY, and $1.21 of EPS, up 34% YoY. This is no longer just a rate-recovery story.
The case depends on three things. First, NII has to keep moving higher. Management explicitly said, "We now expect full year 2026 NII growth to be at the upper end of that 6%-8% range, supported by anticipated loan and deposit growth, fixed rate asset repricing, and balance sheet optimization." That matters because BAC still has meaningful sensitivity to rates and balance-sheet mix, including a stated +$1B NII impact over the next 12 months. Second, expenses have to stay controlled enough for the stronger revenue to drop through. The company raised its operating leverage outlook to 300-400 bps, which is a real uplift from prior >200 bps, even with $18.6B of quarterly non-interest expense. Third, credit must remain stable. So far that piece is cooperating, with management calling out improving card charge-offs and delinquencies both YoY and QoQ.
What the market may still be underpricing is BAC's medium-term efficiency upside from technology. This is one of the few banks with the scale to turn AI from a pilot program into a system-wide cost and service advantage. 300 approved AI use cases, 114 live generative AI cases, and 34 fully implemented is not fluff if it starts reducing servicing costs, improving underwriting throughput, and lifting adviser and call-center productivity across a franchise this large.
Conviction stays high because the setup is not stretched. The stock is 14.0% below its 52-week high, only 1.5% above the 200-day average, and has pulled back 9.98% in the last month despite improving fundamentals. That leaves room for the market to reprice the earnings trajectory rather than defend an already euphoric move. The main thing that would break the thesis is a visible miss on the 2H 2026 operating leverage plan, because that would challenge both management credibility and the case for a higher multiple.
Loan growth, fee income, and markets activity stay firm, AI-driven efficiency starts to show through faster, and BAC closes most of the valuation gap to higher-quality large-bank peers.
Management delivers upper-range NII growth, operating leverage reaches the guided 300-400 bps, and the market values BAC closer to peer earnings multiples.
NII lands below the guided 6%-8% range, expense stays near the elevated $18.6B quarterly run rate, and the stock de-rates toward a lower-quality bank multiple.
Quant call aligns with analyst consensus (Strong Buy: 10 buy / 2 hold / 0 sell).
I don't want a lot of good investments; I want a few outstanding ones.
Forward earnings power is better than the trailing multiple suggests. BAC trades at 12.7x FY2025 EPS, but the business is now being guided for stronger FY2026 NII growth, a +$1B rate-sensitivity benefit over the next 12 months, and materially better operating leverage, which argues that the forward P/E on next-year earnings should sit below the trailing multiple if estimates keep moving up. The moat looks solid today and stronger over the next 3 to 5 years if management keeps converting scale into lower unit costs through AI, because few peers have the deposit base, branch footprint, wealth relationships, markets franchise, and tech budget to industrialize 300 approved AI use cases. Regulation will always cap upside for a money-center bank, but AI is more likely to widen BAC's efficiency advantage than disrupt it, while deposit scale and broad product breadth should keep share stable across consumer, wealth, and corporate banking.
- Valuation remains undemanding at 12.7x P/E versus 15.2x peers, despite FY2025 EPS of $3.88, up 11.3% YoY
- Management now guides to the upper end of 6%-8% FY2026 NII growth and 300-400 bps of full-year operating leverage
- Capital return is real and current, with $8B returned in Q2 2026 and $29.0B of FY2025 FCF supporting buybacks and dividends
- Revenue rose 15% YoY to $31.6B in Q2 2026 and EPS grew 34% YoY to $1.21, showing that earnings acceleration is already in the numbers, not just in guidance.
- Management raised the full-year outlook twice where it matters most for a bank, NII and costs: upper-end 6%-8% NII growth and 300-400 bps operating leverage, up from prior >200 bps.
- Credit is holding up better than feared. Management said card charge-offs and delinquencies improved YoY and QoQ, which matters with sector card delinquency now 2.85% and easing.
- BAC has started converting its scale into productivity. It cited 300 approved AI use cases, 114 live generative AI cases, and 34 fully implemented, which should help offset the $18.6B quarterly expense base over time.
- The stock is still a rates and NII vehicle, and the DCF output at $31.51 is far below the blended target, which shows how sensitive intrinsic value is to longer-run spread and growth assumptions.
- Expense pressure is not gone. Non-interest expense was $18.6B in Q2 2026, up YoY on tech, sales, financial centers, and activity-related costs, so the efficiency story must keep proving itself.
- Second-half comparisons get tougher in the two best Q2 swing factors, with management explicitly flagging harder comps for both NII and investment banking.
- Balance sheet leverage is structurally high, with Debt/Equity 2.43, Debt/EBITDA 18.30, and a 0.07 current ratio, normal for a large bank but still a real constraint if funding markets tighten.
| Metric | Value | Context |
|---|---|---|
| Current price | $56.11 | Reference price for target and scenario framing |
| Quant price target | $67.38 | 20.1% upside, High confidence, basis: earnings_growth_blend |
| FY2025 revenue | $191.6B | +3.8% YoY, showing steady growth before the stronger 2026 acceleration |
| FY2025 EPS | $3.88 | +11.3% YoY, stronger than revenue growth on better profitability |
| Operating margin | 28.7% | Up from 15.2% in the prior fiscal year |
| Net margin | 26.6% | Healthy earnings conversion for a diversified bank |
| Valuation | 12.7x P/E | 2.05x P/S | 1.33x P/B | P/E below 15.2x peer average, P/S roughly in line with 2.1x peers |
| Q2 2026 revenue | $31.6B | +15% YoY, led by NII, wealth fees, investment banking, and trading |
| Q2 2026 EPS | $1.21 | Beat by 7.1%, up 34% YoY |
| FY2026 guidance | NII growth upper end of 6%-8% | operating leverage 300-400 bps | tax rate 21.5% | Raised confidence after strong 1H performance |
| Free cash flow | $29.0B | Supports dividends, buybacks, and balance-sheet optimization |
| 52-week position | $46.12-$65.22 | Stock is 14.0% below the high and 1.5% above the 200-day average of $55.30 |
The biggest risk is that FY2026 earnings momentum fades as 2H comps toughen, because the stock's rerating case depends on management actually delivering the guided 300-400 bps of operating leverage.
Q3 2026 earnings on October 14, 2026, where the key read will be whether NII still tracks the upper end of 6%-8% growth and whether expenses stay consistent with the 300-400 bps operating leverage target.
Ownership is crowded but supportive, with the top 3 institutions holding 70.8% and major holders including BlackRock, Berkshire Hathaway, and Vanguard. Short interest is low at 1.16% of shares outstanding, or 82.3M shares and 2.3 days-to-cover, which says the market is not leaning hard against the story. Near-term options positioning is less friendly, with negative GEX and a zero-gamma level at $57.52, slightly above spot, which can keep volatility elevated into earnings but does not change the medium-term thesis.
12th consecutive quarter of average deposit growth, with non-interest-bearing deposits up 4% YoY, supporting low-cost funding
Q2 2026 strength was significant, with sales & trading +33% YoY and investment banking fees +50%, a major driver of the 15% revenue increase
Wealth fees contributed to broad-based Q2 growth and diversify earnings away from pure spread income
Management's outlook is tied mainly to 2.2% U.S. GDP growth and domestic loan and deposit trends, even though capital-markets activity has global exposure
BAC posted a strong Q2 and pointed to upper-end 6%-8% NII growth with stronger full-year operating leverage.
Execution has been strong and credibility has improved. On the 2024 Q3 call, management said, "We expect NII to grow again in quarter four" and guided to Q4 2024 NII of $14.3B or more plus a return to operating leverage through 2025. Since then, BAC has posted eight straight EPS beats, from 0.81 vs 0.77 in 2024 Q4 through 1.21 vs 1.13 in 2026 Q2, including beats of +11.3%, +10.2%, +9.9%, and +7.1%. The strategic direction has not changed materially: NII repricing, fee growth, deposit growth, and expense discipline remain the playbook. What changed is delivery quality. FY2025 revenue reached $191.6B, up 3.8%, EPS rose 11.3% to $3.88, and Q2 2026 showed much stronger acceleration with 15% revenue growth and 34% EPS growth. That is consistent with the prior promises and supports the view that management has earned the right to be trusted on the current FY2026 guide.
We now expect full year 2026 NII growth to be at the upper end of that 6%-8% range, supported by anticipated loan and deposit growth, fixed rate asset repricing, and balance sheet optimization.
With that first half performance and our continued expectations for a strong second half, we now expect full-year operating leverage to be in the range of 300-400 basis points.
Our revenue grew 15% year-over-year to $31.6 billion. Our net income was $9.1 billion, up 27% from last year.
We remain pretty constructive on loan growth in the second half. No changes there.
We gave you guidance that we're at the top end of a range in operating leverage, all that backs into a strong second half ahead of us.
BAC's moat starts with scale in deposits, payments, wealth, and corporate relationships, which creates a funding and cross-sell advantage that smaller banks cannot match. The proof is in operating data: 12 straight quarters of average deposit growth and growth in non-interest-bearing deposits even in a still-elevated rate environment. That moat is durable because regulation makes it hard to replicate nationwide bank scale, and BAC's ability to spread technology spend across a massive customer base should widen its cost advantage over the next few years.
Capital allocation has been disciplined. BAC generated $29.0B of FY2025 FCF and returned cash steadily, including $8B in Q2 2026 through dividends and buybacks, while deep-dive data shows $6.0B of buybacks and $2.3B of dividends in the latest cash flow snapshot. Management is also optimizing the balance sheet through paydown of repo and institutional CDs in 2H, which is the right use of excess capacity when the stock still trades below peer P/E levels.
BAC rates a BUY with High conviction. The stock still does not fully reflect a bank that is guiding to the upper end of 6%-8% NII growth, targeting 300-400 bps of operating leverage, and consistently beating earnings. At $56.11, the market is paying a below-peer 12.7x earnings multiple for a franchise with improving execution, stable credit, and real capital return. The base case remains the quant engine's $67.38 target. A downgrade would require evidence that second-half NII or expense control is slipping enough to break the operating leverage story.
≣ Full research note tap to expand
Executive Summary
BUY, High conviction. BAC rates a BUY at High conviction. The setup is attractive because the stock sits at $56.11, or 14.0% below its 52-week high, while the company is delivering a cleaner earnings trajectory, with FY2025 EPS up 11.3% and four straight quarters in 2026 of EPS beats. The quant engine's $67.38 target, implying 20.1% upside, is supported by improving NII guidance, stable credit, and a valuation still below the 15.2x peer average.
Investment Thesis
BAC is being valued like a stable but unexciting bank when the earnings path has turned better than that. The core disconnect is simple: the stock trades at 12.7x FY2025 EPS and only 2.05x sales, roughly in line to below peers, yet the operating profile has improved sharply. FY2025 already showed $191.6B of revenue, up 3.8%, and $3.88 of EPS, up 11.3%. Then Q2 2026 accelerated meaningfully, with $31.6B of revenue, up 15% YoY, and $1.21 of EPS, up 34% YoY. This is no longer just a rate-recovery story.
The case depends on three things. First, NII has to keep moving higher. Management explicitly said, "We now expect full year 2026 NII growth to be at the upper end of that 6%-8% range, supported by anticipated loan and deposit growth, fixed rate asset repricing, and balance sheet optimization." That matters because BAC still has meaningful sensitivity to rates and balance-sheet mix, including a stated +$1B NII impact over the next 12 months. Second, expenses have to stay controlled enough for the stronger revenue to drop through. The company raised its operating leverage outlook to 300-400 bps, which is a real uplift from prior >200 bps, even with $18.6B of quarterly non-interest expense. Third, credit must remain stable. So far that piece is cooperating, with management calling out improving card charge-offs and delinquencies both YoY and QoQ.
What the market may still be underpricing is BAC's medium-term efficiency upside from technology. This is one of the few banks with the scale to turn AI from a pilot program into a system-wide cost and service advantage. 300 approved AI use cases, 114 live generative AI cases, and 34 fully implemented is not fluff if it starts reducing servicing costs, improving underwriting throughput, and lifting adviser and call-center productivity across a franchise this large.
Conviction stays high because the setup is not stretched. The stock is 14.0% below its 52-week high, only 1.5% above the 200-day average, and has pulled back 9.98% in the last month despite improving fundamentals. That leaves room for the market to reprice the earnings trajectory rather than defend an already euphoric move. The main thing that would break the thesis is a visible miss on the 2H 2026 operating leverage plan, because that would challenge both management credibility and the case for a higher multiple.
Key Metrics
| Metric | Value | Context | ||
|---|---|---|---|---|
| Current price | $56.11 | Reference price for target and scenario framing | ||
| Quant price target | $67.38 | 20.1% upside, High confidence, basis: earnings_growth_blend | ||
| FY2025 revenue | $191.6B | +3.8% YoY, showing steady growth before the stronger 2026 acceleration | ||
| FY2025 EPS | $3.88 | +11.3% YoY, stronger than revenue growth on better profitability | ||
| Operating margin | 28.7% | Up from 15.2% in the prior fiscal year | ||
| Net margin | 26.6% | Healthy earnings conversion for a diversified bank | ||
| Valuation | 12.7x P/E | 2.05x P/S | 1.33x P/B | P/E below 15.2x peer average, P/S roughly in line with 2.1x peers |
| Q2 2026 revenue | $31.6B | +15% YoY, led by NII, wealth fees, investment banking, and trading | ||
| Q2 2026 EPS | $1.21 | Beat by 7.1%, up 34% YoY | ||
| FY2026 guidance | NII growth upper end of 6%-8% | operating leverage 300-400 bps | tax rate 21.5% | Raised confidence after strong 1H performance |
| Free cash flow | $29.0B | Supports dividends, buybacks, and balance-sheet optimization | ||
| 52-week position | $46.12-$65.22 | Stock is 14.0% below the high and 1.5% above the 200-day average of $55.30 |
Financial Strength
BAC's financial profile is stronger than the raw bank leverage optics imply. The balance sheet carries $732.1B of debt and a low 0.07 current ratio, but those figures are normal to bank funding models and need to be read alongside stable deposits, improving credit, and substantial internal cash generation. What matters more is that BAC produced $29.0B of FCF, holds a 76/100 quality score, and is showing better earnings conversion, with operating margin reaching 28.7% and net margin 26.6%. Margin trajectory is moving the right way because NII, fee income, and balance-sheet optimization are all helping at once.
Competitive Position
BAC's moat starts with scale in deposits, payments, wealth, and corporate relationships, which creates a funding and cross-sell advantage that smaller banks cannot match. The proof is in operating data: 12 straight quarters of average deposit growth and growth in non-interest-bearing deposits even in a still-elevated rate environment. That moat is durable because regulation makes it hard to replicate nationwide bank scale, and BAC's ability to spread technology spend across a massive customer base should widen its cost advantage over the next few years.
Management & Guidance
Management is guiding from a position of momentum, not hope. The most important update from the Q2 2026 call was the move to the upper end of 6%-8% NII growth and the increase in expected operating leverage to 300-400 bps, while keeping a 21.5% tax rate assumption. The guidance looks credible because BAC has beaten EPS estimates in each of the last eight quarters, and because the call-level fundamentals support it: deposit growth has continued for 12 straight quarters, management still sounds constructive on loan growth, and credit trends in cards are improving. The watch item is expenses, since $18.6B of quarterly non-interest expense leaves less room for execution slips in the second half.
Segment Analysis
- Consumer and deposit franchise (N/A): 12th consecutive quarter of average deposit growth, with non-interest-bearing deposits up 4% YoY, supporting low-cost funding
- Markets and investment banking (N/A): Q2 2026 strength was significant, with sales & trading +33% YoY and investment banking fees +50%, a major driver of the 15% revenue increase
- Wealth and fee businesses (N/A): Wealth fees contributed to broad-based Q2 growth and diversify earnings away from pure spread income
- Geography (Primarily U.S.): Management's outlook is tied mainly to 2.2% U.S. GDP growth and domestic loan and deposit trends, even though capital-markets activity has global exposure
Capital Allocation
Capital allocation has been disciplined. BAC generated $29.0B of FY2025 FCF and returned cash steadily, including $8B in Q2 2026 through dividends and buybacks, while deep-dive data shows $6.0B of buybacks and $2.3B of dividends in the latest cash flow snapshot. Management is also optimizing the balance sheet through paydown of repo and institutional CDs in 2H, which is the right use of excess capacity when the stock still trades below peer P/E levels.
Management Execution & Track Record
Execution has been strong and credibility has improved. On the 2024 Q3 call, management said, "We expect NII to grow again in quarter four" and guided to Q4 2024 NII of $14.3B or more plus a return to operating leverage through 2025. Since then, BAC has posted eight straight EPS beats, from 0.81 vs 0.77 in 2024 Q4 through 1.21 vs 1.13 in 2026 Q2, including beats of +11.3%, +10.2%, +9.9%, and +7.1%. The strategic direction has not changed materially: NII repricing, fee growth, deposit growth, and expense discipline remain the playbook. What changed is delivery quality. FY2025 revenue reached $191.6B, up 3.8%, EPS rose 11.3% to $3.88, and Q2 2026 showed much stronger acceleration with 15% revenue growth and 34% EPS growth. That is consistent with the prior promises and supports the view that management has earned the right to be trusted on the current FY2026 guide.
Positioning & Flows
Ownership is crowded but supportive, with the top 3 institutions holding 70.8% and major holders including BlackRock, Berkshire Hathaway, and Vanguard. Short interest is low at 1.16% of shares outstanding, or 82.3M shares and 2.3 days-to-cover, which says the market is not leaning hard against the story. Near-term options positioning is less friendly, with negative GEX and a zero-gamma level at $57.52, slightly above spot, which can keep volatility elevated into earnings but does not change the medium-term thesis.
Bull Case
- Revenue rose 15% YoY to $31.6B in Q2 2026 and EPS grew 34% YoY to $1.21, showing that earnings acceleration is already in the numbers, not just in guidance.
- Management raised the full-year outlook twice where it matters most for a bank, NII and costs: upper-end 6%-8% NII growth and 300-400 bps operating leverage, up from prior >200 bps.
- Credit is holding up better than feared. Management said card charge-offs and delinquencies improved YoY and QoQ, which matters with sector card delinquency now 2.85% and easing.
- BAC has started converting its scale into productivity. It cited 300 approved AI use cases, 114 live generative AI cases, and 34 fully implemented, which should help offset the $18.6B quarterly expense base over time.
Bear Case
- The stock is still a rates and NII vehicle, and the DCF output at $31.51 is far below the blended target, which shows how sensitive intrinsic value is to longer-run spread and growth assumptions.
- Expense pressure is not gone. Non-interest expense was $18.6B in Q2 2026, up YoY on tech, sales, financial centers, and activity-related costs, so the efficiency story must keep proving itself.
- Second-half comparisons get tougher in the two best Q2 swing factors, with management explicitly flagging harder comps for both NII and investment banking.
- Balance sheet leverage is structurally high, with Debt/Equity 2.43, Debt/EBITDA 18.30, and a 0.07 current ratio, normal for a large bank but still a real constraint if funding markets tighten.
Valuation & Price Target
Engine price target $67.38 (+20.1% vs current), High confidence.
- P/E Multiple: $75.08 (28% weight)
- P/S Multiple: $63.62 (20% weight)
- Quality-adjusted: $73.2 (20% weight)
- DCF: $31.51 (7% weight)
This rating aligns with the quant baseline BUY and does not need a heroic assumption set to do so. The engine's $67.38 target looks reasonable because BAC trades at just 12.7x earnings versus 15.2x peers while management is guiding to the upper end of 6%-8% NII growth and 300-400 bps of operating leverage. The low-risk profile is also supported by the company-specific evidence: eight straight EPS beats, improving credit trends, and $29.0B of FCF. Sell-side consensus is also positive, but that is only a context check, not the basis for the call.
Risk Assessment
Risk score 29/100 (Low). The biggest risk is that FY2026 earnings momentum fades as 2H comps toughen, because the stock's rerating case depends on management actually delivering the guided 300-400 bps of operating leverage.
The Bottom Line
BAC rates a BUY with High conviction. The stock still does not fully reflect a bank that is guiding to the upper end of 6%-8% NII growth, targeting 300-400 bps of operating leverage, and consistently beating earnings. At $56.11, the market is paying a below-peer 12.7x earnings multiple for a franchise with improving execution, stable credit, and real capital return. The base case remains the quant engine's $67.38 target. A downgrade would require evidence that second-half NII or expense control is slipping enough to break the operating leverage story.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr